Have Questions?

Global Headquarters

Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157

North America

Tel: 1-617-573-9450
Fax: 1-617-573-9542


Tel: +81 (0)80-1164-4754

Request a Demo

What our customers are saying

When I think of the future, I think of EvaluatePharma

Senior Director,
Global pharmaceutical company

ASCO: Skirmishes break out in the great lung cancer battle

EP Vantage ASCO Preview EP Vantage ASCO Preview EP Vantage ASCO Preview

Download Report

The battle for market share in first-line non-small-cell lung cancer has reached fever pitch. As investors’ and doctors’ attention now turns to the annual Asco meeting a de-escalation of hostilities looks unlikely.

Merck & Co’s Keytruda looks increasingly likely to seize the lion’s share of this market. This does not mean that there is no longer anything to play for, but the battle now seems to be turning into a series of skirmishes over ever smaller slices of the pie.

Confirm your details on form below to download this report